Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

22
Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
22
Pharmacovigilance01:19

Pharmacovigilance

1.8K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.8K
Dosage Regimens: Designs and Approaches01:28

Dosage Regimens: Designs and Approaches

367
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
367
Pharmaceutical Alternatives: Excipients and Impurities-Related Therapeutic Nonequivalence01:19

Pharmaceutical Alternatives: Excipients and Impurities-Related Therapeutic Nonequivalence

199
Pharmaceutical products contain more than just the active drug; they also contain various excipients such as binders, solubilizers, stabilizers, preservatives, and other elements. In some cases, impurities or contaminants might be present. Traditionally, quality control in pharmaceuticals has primarily focused on the analysis of the active drug, often overlooking the impact of these additional components. The recent issue with heparin contamination by over-sulfated chondroitin sulfate, a...
199
Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence01:27

Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence

197
Changes in polymorphic forms can significantly influence the bioavailability of poorly soluble drugs. Although the FDA defines pharmaceutical equivalence based on having the same active ingredient, dosage form, and route of administration, it does not automatically disqualify products with different polymorphic forms. This means two products with different polymorphs can still be deemed pharmaceutically equivalent. However, polymorphic differences can affect properties like wettability,...
197
Biopharmaceutics and Pharmacokinetics: Overview01:28

Biopharmaceutics and Pharmacokinetics: Overview

4.4K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
4.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Short-term effect of tirzepatide on serum calcitonin in adults with obesity.

Endocrine·2026
Same author

Six-Month Real-World Effectiveness, Persistence and Safety of Low-to-Moderate Dose Tirzepatide in Adults With Obesity: A Multicentre Observational Study.

Diabetes, obesity & metabolism·2026
Same author

Self-Management, Adherence, and the Role of Pharmaceutical Care in Patients with T2DM in Primary Practice: A Cross-Sectional Survey in Bulgaria.

Pharmacy (Basel, Switzerland)·2026
Same author

A real-world study of tirzepatide for weight loss in adults without diabetes mellitus.

International journal of obesity (2005)·2025
Same author

Targeting senescent microglia in progressive multiple sclerosis: a geroscience-informed approach.

Frontiers in immunology·2025
Same author

Short-term effects of low-dose tirzepatide on lipid profile, glucose homeostasis and hepatic steatosis index in adults with obesity, but without diabetes mellitus: a prospective observational study.

Journal of diabetes and its complications·2025

Related Experiment Video

Updated: Feb 21, 2026

The Cultivation, Growth, and Viability of Lactic Acid Bacteria: A Quality Control Perspective
04:40

The Cultivation, Growth, and Viability of Lactic Acid Bacteria: A Quality Control Perspective

Published on: June 16, 2022

9.5K

Pharmacy Practice and Education in Bulgaria.

Valentina Petkova1, Jeffrey Atkinson2

  • 1Faculty of Pharmacy, Medical University-Sofia, 2-Dunav Street, 1000 Sofia, Bulgaria. petkovav1972@yahoo.com.

Pharmacy (Basel, Switzerland)
|October 4, 2017
PubMed
Summary

Bulgarian pharmacists hold a monopoly on dispensing various health products. Pharmacist education includes a five-year Master of Science in Pharmacy (M.Sc. Pharm.) degree, preparing them for diverse roles in community and hospital settings.

Keywords:
Bulgariaeducationpharmacypractice

More Related Videos

Laboratory Scale Production and Purification of a Therapeutic Antibody
09:54

Laboratory Scale Production and Purification of a Therapeutic Antibody

Published on: January 24, 2017

18.4K
Evaluation of Drug Sorption to PVC- and Non-PVC-based Tubes in Administration Sets Using a Pump
06:08

Evaluation of Drug Sorption to PVC- and Non-PVC-based Tubes in Administration Sets Using a Pump

Published on: March 11, 2017

11.1K

Related Experiment Videos

Last Updated: Feb 21, 2026

The Cultivation, Growth, and Viability of Lactic Acid Bacteria: A Quality Control Perspective
04:40

The Cultivation, Growth, and Viability of Lactic Acid Bacteria: A Quality Control Perspective

Published on: June 16, 2022

9.5K
Laboratory Scale Production and Purification of a Therapeutic Antibody
09:54

Laboratory Scale Production and Purification of a Therapeutic Antibody

Published on: January 24, 2017

18.4K
Evaluation of Drug Sorption to PVC- and Non-PVC-based Tubes in Administration Sets Using a Pump
06:08

Evaluation of Drug Sorption to PVC- and Non-PVC-based Tubes in Administration Sets Using a Pump

Published on: March 11, 2017

11.1K

Area of Science:

  • Pharmacy Practice
  • Pharmaceutical Education

Background:

  • Pharmacies in Bulgaria possess a monopoly on dispensing authorized medicinal products, medical devices, food additives, cosmetics, and sanitary/hygienic articles.
  • Pharmacists (Aptekari) function as responsible pharmacists, owners, and managers, requiring specific educational qualifications.

Purpose of the Study:

  • To outline the educational pathways and scope of practice for pharmacists and assistant pharmacists in Bulgaria.
  • To describe the structure of pharmacy education and practice within the Bulgarian healthcare system.

Main Methods:

  • The study reviews the curriculum and training requirements for pharmacists (M.Sc. Pharm.) and assistant pharmacists (Pomoshnik-farmacevti) in Bulgaria.
  • It details the integration of various pharmaceutical disciplines and practical training within Bulgarian pharmacy higher education institutions.

Main Results:

  • Pharmacist education in Bulgaria is a five-year Master of Science in Pharmacy (M.Sc. Pharm.) program, including a six-month traineeship and culminating in state examinations.
  • Assistant pharmacists undergo a three-year degree with a six-month traineeship, enabling them to prepare medicines and dispense over-the-counter (OTC) medications under supervision.
  • Specialized areas like industrial and clinical (hospital) pharmacy are integrated into some curricula, such as at the Medical University of Sofia.

Conclusions:

  • Bulgarian pharmacy education and practice are structured similarly to other European Union member states.
  • The system ensures qualified pharmacists and assistant pharmacists capable of managing dispensing and pharmaceutical care within their legal scope.